Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel
1003020W0AAAAAA
|
Heparinoid (Topical Antirheumatic) | Heparinoid | Musculoskeletal and Joint Diseases | 10,422 |
|
Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% crm
1003020W0AAABAB
|
Heparinoid (Topical Antirheumatic) | Heparinoid | Musculoskeletal and Joint Diseases | 2,647 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.